Narasimha Swamy
Endocrinology
Diabetes and Nutrition
Department of Medicine
Boston University School of Medicine
USA
Name/email consistency: low
- Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Swamy, N., Chen, T.C., Peleg, S., Dhawan, P., Christakos, S., Stewart, L.V., Weigel, N.L., Mehta, R.G., Holick, M.F., Ray, R. Clin. Cancer Res. (2004)